MarketCap
Facebook
X
TelegramFluidigm Corporation Anteile 2011-2026 | FLDM
Anteile Jährlich Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 74.3 M | 66.8 M | 39.7 M | 33 M | 29 M | 28.7 M | 27.8 M | 25.5 M | 22.1 M | 17.8 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 74.3 M | 17.8 M | 36.5 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
304 M | $ 117.31 | 1.94 % | $ 35.7 B |  USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 16.76 | 4.39 % | $ 893 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 2.2 | -4.35 % | $ 9.73 M | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.44 | 5.11 % | $ 1.92 M | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 23.52 | 1.69 % | $ 653 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 177.53 | 1.05 % | $ 8.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 498.33 | 0.97 % | $ 14.4 B | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.6 | 5.63 % | $ 426 M | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 195.23 | 2.99 % | $ 139 B | USA |
 |
NeoGenomics
NEO
|
128 M | $ 7.96 | 3.51 % | $ 1.02 B | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
159 M | $ 126.4 | 4.52 % | $ 20.1 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 15.33 | 6.2 % | $ 464 M | USA |
 |
Guardant Health
GH
|
125 M | $ 81.93 | 4.24 % | $ 10.3 B | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 6.69 | 0.15 % | $ 279 M | USA |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.84 | 5.58 % | $ 92.2 K | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.09 | -1.88 % | $ 4.8 M | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 28.55 | 0.87 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 109.57 | 2.58 % | $ 9.04 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.66 | 0.05 % | $ 2.68 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 264.34 | 1.31 % | $ 22 B | USA |
 |
Natera
NTRA
|
98.4 M | $ 200.92 | 4.08 % | $ 19.8 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 119.65 | 2.14 % | $ 5.59 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 81.32 | 0.91 % | $ 5.49 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Neuronetics
STIM
|
66 M | $ 1.39 | 2.59 % | $ 91.7 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 191.77 | 0.13 % | $ 21.3 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.34 | -0.9 % | $ 2.03 B | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 5.19 | 5.06 % | $ 4.08 M | USA |
 |
Organovo Holdings
ONVO
|
1.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 M | - | -16.95 % | $ 1.54 M | USA |